drugset / Trial / NCT02850848

Pharmacokinetics of Two Formulations of Entecavir

NCT02850848

RandomizedParallel-groupOpen-labelTreatment

Summary

A Randomized, Parallel, Single-Dose Study to Evaluate the Pharmacokinetics of a Test Formulation of Entigin Film Coated Tablet 0.5mg (Entecavir 0.5 mg), Compared to an Equivalent Dose of a Reference Drug Product (Baraclude 0.5mg Tablets) in Healthy

Timeline

Start
2015-12
Primary completion
2016-02
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Entecavir Small molecule 0.5 mg